Literature DB >> 12967929

Atypical beta-adrenoceptors, different from beta 3-adrenoceptors and probably from the low-affinity state of beta 1-adrenoceptors, relax the rat isolated mesenteric artery.

Hanna Kozłowska1, Urszula Szymska, Eberhard Schlicker, Barbara Malinowska.   

Abstract

(1) We examined whether beta3- and/or atypical beta-adrenoceptors relax the rat isolated mesenteric artery. (2) Mesenteric arteries precontracted with phenylephrine were relaxed by beta-agonists with the following potencies (pD2): nonselective agonist isoprenaline (6.00)>nonconventional partial agonist cyanopindolol (5.45)>beta2-agonist fenoterol (4.98)>nonconventional partial agonist CGP 12177 (4.19)>beta3-agonist ZD 2079 (3.72). The beta3-agonist CL 316243 1 mm relaxed the vessel only marginally. (3) The concentration-response curves (CRCs) for cyanopindolol, CGP 12177 and ZD 2079 were not affected by the nonselective beta-antagonist propranolol 0.3 microm, the beta2-antagonist ICI 118551 1 microm and by CL 316243 60 microm, but shifted to the right by bupranolol (pA2 5.3-5.7), CGP 20712 (5.4) and SR 59230A (6.5-6.7) (the latter three drugs block atypical and/or beta3-adrenoceptors at high concentrations). (4) The CRC for isoprenaline was shifted to the right by propranolol (pA2 7.0) but, in the presence of propranolol 0.3 microm, not affected by SR 59230A 1 microm. The CRC for fenoterol was shifted to the right by propranolol (pA2 6.9) and ICI 118551 (6.8). (5) Removal of endothelium diminished the vasorelaxant effects of cyanopindolol, CGP 12177 and ZD 2079. (6) Fenoterol and cyanopindolol also relaxed (endothelium-intact) mesenteric arteries precontracted with serotonin. The relaxant effect of cyanopindolol was antagonized by bupranolol to about the same degree as in phenylephrine-contracted vessels. (7) In conclusion, beta2- and atypical beta-adrenoceptors (but not beta3-adrenoceptors) relax the rat mesenteric artery. The atypical beta-adrenoceptor, which is partially located endothelially, may differ from the low-affinity state of the beta1-adrenoceptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967929      PMCID: PMC1574016          DOI: 10.1038/sj.bjp.0705421

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

Review 1.  Adrenergic and muscarinic receptors in the human heart.

Authors:  O E Brodde; M C Michel
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

2.  Beta-3 adrenergic stimulation of L-type Ca(2+) channels in rat portal vein myocytes.

Authors:  P Viard; N Macrez; F Coussin; J L Morel; J Mironneau
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  Role of endothelium/nitric oxide in atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.

Authors:  L Brawley; A M Shaw; A MacDonald
Journal:  Eur J Pharmacol       Date:  2000-06-16       Impact factor: 4.432

Review 4.  Vascular adrenoceptors: an update.

Authors:  S Guimarães; D Moura
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

5.  Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.

Authors:  L Brawley; A M Shaw; A MacDonald
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

6.  Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.

Authors:  J N Trochu; V Leblais; Y Rautureau; F Bévérelli; H Le Marec; A Berdeaux; C Gauthier
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

7.  Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology.

Authors:  A J Kaumann; S Engelhardt; L Hein; P Molenaar; M Lohse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-01       Impact factor: 3.000

8.  Coexistence of at least three distinct beta-adrenoceptors in human internal mammary artery.

Authors:  M Shafiei; G Omrani; M Mahmoudian
Journal:  Acta Physiol Hung       Date:  2000

9.  Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cyclic adenosine monophosphate-dependent pathway.

Authors:  E Tagaya; J Tamaoki; H Takemura; K Isono; A Nagai
Journal:  Lung       Date:  1999       Impact factor: 2.584

10.  Effects of propranolol and L-NAME on beta-adrenoceptor-mediated relaxation in rat carotid artery.

Authors:  A MacDonald; M McLean; L MacAulay; A M Shaw
Journal:  J Auton Pharmacol       Date:  1999-06
View more
  11 in total

Review 1.  The 'state' of beta-adrenoceptors.

Authors:  Peter Molenaar
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

2.  Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries.

Authors:  Ana M Briones; Craig J Daly; Francesc Jimenez-Altayo; Sonia Martinez-Revelles; Jose M Gonzalez; John C McGrath; Elisabet Vila
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

3.  Positive inotropic and lusitropic effects mediated via the low-affinity state of beta1-adrenoceptors in pithed rats.

Authors:  Agnieszka Zakrzeska; Eberhard Schlicker; Grzegorz Kwolek; Hanna Kozłowska; Barbara Malinowska
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

4.  Do low-affinity states of beta-adrenoceptors have roles in physiology and medicine?

Authors:  Jonathan R S Arch
Journal:  Br J Pharmacol       Date:  2004-11       Impact factor: 8.739

5.  beta-adrenoceptor mediated responses in rat pulmonary artery: putative role of TASK-1 related K channels.

Authors:  Detlef Bieger; Kakoli Parai; Carol Ann Ford; Reza Tabrizchi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-25       Impact factor: 3.000

6.  Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptor.

Authors:  Jillian G Baker; Richard G W Proudman; Stephen J Hill
Journal:  Mol Pharmacol       Date:  2014-03-07       Impact factor: 4.436

7.  Role of beta2-adrenoceptors (beta-AR), but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-mediated relaxation of rat intrapulmonary artery.

Authors:  Fabrice Pourageaud; Véronique Leblais; Nadège Bellance; Roger Marthan; Bernard Muller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-08-26       Impact factor: 3.000

8.  A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptors.

Authors:  Jillian G Baker
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

9.  Stimulated release of a hyperpolarizing factor (ADHF) from mesenteric artery perivascular adipose tissue: involvement of myocyte BKCa channels and adiponectin.

Authors:  A H Weston; I Egner; Y Dong; E L Porter; A M Heagerty; G Edwards
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

10.  ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.

Authors:  Nataraj Brahmadevara; Angus M Shaw; Allan MacDonald
Journal:  Br J Pharmacol       Date:  2004-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.